CMS’s Price Transparency Initiatives for 2020
CMS released three proposed rules on July 29, which include payment updates for outpatient and physician services and expanded price transparency initiatives.
CMS released three proposed rules on July 29, which include payment updates for outpatient and physician services and expanded price transparency initiatives.
HHS is making progress on reducing the backlog of Medicare appeals at the administrative law judge level, according to a recent status report.
In 2015, cancer deaths cost the U.S. $94 billion in lost earnings, according to a study published in JAMA Oncology.
A new study provides more evidence that America’s ongoing opioid epidemic was fueled by doctors prescribing more painkillers than patients needed — leading to what’s now the deadliest drug overdose crisis in US history.
Two-thirds of drug deaths around the world were caused by opioids in 2017, and that proportion was even higher in the U.S., where overdose deaths reached a new high, according to a report from the United Nations.
The Trump administration seeks cut opioid prescription fills by 33 percent in three years through better education and adherence to pain-management ...
A new study published in the Journal of the American Medical Association, which examined prices for the 49 top-selling drugs between January 2012 and December 2017, found virtually all brands of drugs rose in price on a regular basis.
Multispecialty medical group and integrated delivery system revenue is increasingly risk-based, but these organizations continue to experience barriers that slow their progress toward total value-based healthcare, according to a new survey.
By using external reference pricing to match U.S. drug prices to those in Japan, the U.K. or Canada, Medicare could have saved nearly $73 billion in 2018 ...
The Trump administration seeks cut opioid prescription fills by 33 percent in three years through better education and adherence to pain-management ...